Approval · Notice of Compliance 30940 · 2023
SILDENAFIL: Notice of Compliance 30940
Issued June 7, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30940
- Date
- June 7, 2023
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Manufacturers
- Canadian reference product
- VIAGRA (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SILDENAFIL | 02400693 | Marketed |
| SILDENAFIL | 02400707 | Marketed |
| SILDENAFIL | 02400715 | Marketed |
Medicinal ingredients
- SILDENAFIL 25 MG per TAB
- SILDENAFIL 50 MG per TAB
- SILDENAFIL 100 MG per TAB